Welcome to the detailed analysis for fortressbiotech.com. This domain is officially recognized as Fortress Biotech, Inc. (FBIO). According to their official web presence, their primary focus is: "Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income.…".
"Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million"
"Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO® (copper histidinate), the First and Only Approved Treatment for Menkes Disease in the United States; Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval was transferred from Sentynl Therapeutics to Cyprium"
"Fortress Biotech Closes Sale of Subsidiary Checkpoint Therapeutics"
"Journey Medical Corporation Announces U.S. FDA Approval of Emrosi (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea"
By comparing fortressbiotech.com to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to fortressbiotech.com.
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
As of August 15, 2026, fortressbiotech.com holds an estimated domain authority score of 67/100 based on our VisitRank tracking algorithms.
You can find the best alternatives and similar sites to fortressbiotech.com in our explore section, which includes competitors in the E-commerce & Retail sector.
Common Misspellings & Typo Domains for fortressbiotech.com: